Department of Medicine, Pulmonary and Critical Care Medicine Fellowship, Lifespan Hospitals, Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI 02903, USA.
Department of Medicine, Obstetric Medicine Division, McGill University Health Center and Research Institute of the McGill University Health Center, 1001 Decarie Boulevard, D05.5839.3, Montreal, Quebec H4A 3J1, Canada.
Clin Chest Med. 2021 Sep;42(3):483-496. doi: 10.1016/j.ccm.2021.04.008.
Maternal mortality is increasing in the United States; many maternal deaths are linked to substandard care and withholding diagnostic tests or therapeutic options for fear of harm. Respiratory conditions are common in this population; however, caring for pregnant women with respiratory disease is complicated by physiologic changes. Safety of diagnostic tests as well as therapeutic interventions, changes in pharmacodynamics, and potential teratogenicity complicate the care of this population further. Appropriate care of pregnant women with respiratory conditions requires a good understanding of these nuances in the management, to provide appropriate care and improve the health and well-being of pregnant women.
美国的孕产妇死亡率正在上升;许多孕产妇死亡与护理标准不达标以及出于担心伤害而拒绝诊断性检查或治疗选择有关。该人群中常见的是呼吸道疾病;然而,由于生理变化,照顾患有呼吸道疾病的孕妇变得复杂。诊断性检查的安全性以及治疗干预、药效学的变化和潜在的致畸性使这一人群的护理进一步复杂化。适当照顾患有呼吸道疾病的孕妇需要很好地理解管理中的这些细微差别,以提供适当的护理并改善孕妇的健康和福祉。